Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Oct. 13: Vanderbilt University Medical Center Hosts Bone Marrow Disorders Symposium


 

Vanderbilt University Medical Center (VUMC) clinicians will host an educational symposium on bone marrow disorders, including bone marrow failure, acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The free symposium for health care practitioners, sponsored by VUMC and the Aplastic Anemia and MDS International Foundation, will be held Friday, Oct. 13, 11:30 a.m. - 6 p.m., at the Omni Nashville Hotel, 250 5th Ave. South.

Bone marrow disease specialists from VUMC and other leading medical centers will provide the latest information on the diagnosis and management of bone marrow failure and myeloid malignancies based on current clinical practice guidelines and recent research studies. The expert faculty will provide insight into these rare disorders and offer recommendations for clinical practice.

Course director Michael Savona, M.D., associate professor of Medicine and director of Hematology Research at VUMC notes, "This is a unique opportunity for our local and referring medical communities to hear about exciting new drug approvals and treatment considerations specifically for myeloid cancers and bone marrow failure."

The educational sessions are appropriate for health care professionals working with patients with leukemia, MDS and other bone marrow failure, including hematologists, advance practice providers, oncologists, primary care physicians, pediatricians, pathologists, residents/fellows, physician assistants, nurses and nurse practitioners, and pharmacists. The activity is approved for continuing medical education (CME) credits.

VUMC faculty include Stephen Strickland Jr., M.D., M.S.C.I., assistant professor of Medicine and clinical director of Acute Leukemia, who will discuss newly approved therapy for AML; Michael Byrne, D.O., assistant professor of Medicine, who will review post-hematopoietic stem cell transplant relapse in AML; and Tamara Moyo, M.D., Ph.D., instructor of Medicine, who will discuss bone marrow failure and the role of stem cell transplant in patients with bone marrow failure.

They will be joined by Daniel Pollyea, M.D., M.S., clinical director of Leukemia Services at the University of Colorado School of Medicine, who will highlight new therapies including BCL-2 inhibitors; Mrinal Patnaik, M.B.B.S., assistant professor of Medicine at the Mayo Clinic, who will review strategies for overlaps syndromes (such as CMML) that have properties of both MDS and myeloproliferative neoplasms; and Amy DeZern, M.D., M.H.S., assistant professor of Medicine at Johns Hopkins School of Medicine, who will discuss the different types of myelodysplastic syndromes.

To register for the event, visit https://friendraising.donorpro.com/campaigns/390 or contact houk@aamds.org for more information.

 
Share:

Related Articles:


Recent Articles

April 12 Proclaimed Dr. Matthew Walker, Sr. Day

Mayor David Briley Presented Recognition at Event on April 12 at Meharry Medical College

Read More

Building on BUILD Health

In a new report from the de Beaumont Foundation, health system executives weigh in on working outside their facilities' four walls to impact community health

Read More

Addressing Physician Burnout

In recognition that physician burnout is increasing, the AMA and other companies and organizations have begun tackling the critical issue from a variety of vantage points

Read More

Study of Mucus May Help Guide Sinusitis Treatment

By April, nearly one-third of the U.S. is already experiencing high pollen levels while the weather and temperatures continue to fluctuate, aggravating sinus symptoms.

Read More

Tennessee Department Of Health Warns Of Phone Scam Attempt

Local and Out-of-State Residents May be Targeted

Read More

Senator Alexander Pushes for Better Data and Transparency of the Federal 340B Drug Pricing Program

Today, United States Senator Lamar Alexander (R-Tenn.) - chairman of the Senate's health committee - pushed for better data and transparency of the federal 340B Drug Pricing Program to ensure it's fulfilling its purpose to help hospitals care for low-income patients.

Read More

Blackburn Introduces Bipartisan Addiction & Recovery Act

Blackburn Introduces Bipartisan Comprehensive Addiction and Recovery Act 2.0 to Combat Opioid Epidemic

Read More

All In: Conversations on Health in Nashville

Is a person's zip code more important than their genetic code? Data suggests investing in social care could have a significant impact on healthcare.

Read More

Cumberland Pharmaceuticals Launches Oncology Division

Nashville-based Cumberland Pharmaceuticals has announced expansion into oncology support with the launch of a new corporate division.

Read More

Caring for Generations

Primary care provider Lorraine Charles, MD, has a passion for caring for the underserved in Nashville and beyond.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: